Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

QuidelOrtho Corporation - Common Stock (NQ:QDEL)

23.40 -5.40 (-18.75%)
Streaming Delayed Price Updated: 3:51 PM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about QuidelOrtho Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
News headline image
QDEL Stock Slumps On Mixed Wall Street Price Target Revisions After Q4 Report ↗
UBS, Citi and JPMorgan revised their price targets on the stock on the heels of the company issuing fresh guidance for fiscal 2026. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
QuidelOrtho (QDEL) Q4 2025 Earnings Transcript ↗
QuidelOrtho (QDEL) Q4 2025 Earnings Transcript 
Via The Motley Fool
Topics World Trade
QuidelOrtho Corp (NASDAQ:QDEL) Beats Q4 Earnings Estimates Despite After-Hours Stock Decline ↗
Via Chartmill
News headline image
QuidelOrtho (NASDAQ:QDEL) Exceeds Q4 CY2025 Expectations
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 2.2% year on year to $723.6 million. The company’s... 
Via StockStory
News headline image
Earnings To Watch: QuidelOrtho (QDEL) Reports Q4 Results Tomorrow
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) will be reporting earnings this Wednesday after the bell. Here’s what to expect. 
Via StockStory
Topics World Trade
QuidelOrtho Corp (NASDAQ:QDEL) Shows High-Quality Technical Breakout Setup ↗
Via Chartmill
News headline image
Earnings Scheduled For November 5, 2025 ↗
 
Via Benzinga
News headline image
3 Volatile Stocks We’re Skeptical Of
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced... 
Via StockStory
News headline image
3 Stocks Under $50 Walking a Fine Line
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some... 
Via StockStory
News headline image
3 Reasons to Sell QDEL and 1 Stock to Buy Instead
Since July 2025, QuidelOrtho has been in a holding pattern, posting a small return of 4.6% while floating around $26.60. 
Via StockStory
News headline image
3 Reasons QDEL is Risky and 1 Stock to Buy Instead
QuidelOrtho trades at $27.60 per share and has stayed right on track with the overall market, gaining 5.8% over the last six months. At the same time, the S&P 500 has returned 8.8%. 
Via StockStory
Topics Stocks
News headline image
QuidelOrtho (NASDAQ:QDEL) Q3 Earnings: Leading The Medical Devices & Supplies - Imaging, Diagnostics Pack
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at medical devices & supplies - imaging,... 
Via StockStory
Topics Artificial Intelligence
News headline image
Millrose Properties Stock Has Surged 48% Since February Debut — So Why Did One Investor Sell a $23 Million Stake? ↗
A newly public real-estate platform is putting up numbers that look far more seasoned than its age. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why One Investor Bought $67.5 Million in Array Digital Infrastructure Stock ↗
One fund just made a bold bet on a telecom stock undergoing a big transformation 
Via The Motley Fool
News headline image
Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge ↗
This fund just doubled down on a stock that’s suddenly delivering the earnings momentum it’s promised for years. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highs ↗
A beaten-down diagnostics stock is quietly tightening margins and drawing fresh institutional conviction—here’s what that means for long-term investors. 
Via The Motley Fool
News headline image
1 Russell 2000 Stock with Solid Fundamentals and 2 We Turn Down
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher... 
Via StockStory
News headline image
Why QuidelOrtho (QDEL) Stock Is Up Today
Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) jumped 2.6% in the morning session after a director, Joseph D Jr. Wilkins, purchased shares of the company's stock. Wilkins acquired... 
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
3 Cash-Burning Stocks Walking a Fine Line
While some companies burn cash to fuel expansion, others struggle to turn spending into sustainable growth. A high cash burn rate without a strong balance sheet can leave investors exposed to... 
Via StockStory
News headline image
1 of Wall Street’s Favorite Stock to Target This Week and 2 We Ignore
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
Topics Supply Chain
News headline image
QuidelOrtho (QDEL) Stock Trades Up, Here Is Why
Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) jumped 4.5% in the afternoon session after its CEO, Brian J. Blaser, purchased 23,500 shares of the company for a total of $501,577. 
Via StockStory
Topics Artificial Intelligence Government
News headline image
BrightSpring Health Services, 10x Genomics, QuidelOrtho, Medpace, and Fortrea Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after reports revealed the Trump administration considered extending the Affordable Care Act (ACA) subsidies. These subsidies, which are government... 
Via StockStory
Topics Economy Government
News headline image
QuidelOrtho (QDEL) Shares Skyrocket, What You Need To Know
Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) jumped 14.9% in the afternoon session after the company's President and CEO, Brian Blaser, purchased 23,500 shares of company stock.... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
3 Unprofitable Stocks We Keep Off Our Radar
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. 
Via StockStory
News headline image
5 Revealing Analyst Questions From QuidelOrtho’s Q3 Earnings Call
QuidelOrtho’s third quarter was marked by a positive market reaction, reflecting solid execution despite a year-on-year decline in reported sales. Management attributed the quarter’s underlying... 
Via StockStory
Topics Earnings
News headline image
Viatris, Oscar Health, BioMarin Pharmaceutical, QuidelOrtho, and Bausch + Lomb Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
Why QuidelOrtho (QDEL) Stock Is Down Today
Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) fell 12.8% in the morning session after it reported disappointing third-quarter financial results and reduced its full-year earnings... 
Via StockStory
News headline image
QDEL Q3 Deep Dive: Margin Progress and Cost Actions Offset Headwinds in Core Diagnostics
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) announced better-than-expected revenue in Q3 CY2025, but sales fell by 3.7% year on year to $699.9 million. The company expects the full year’s... 
Via StockStory
Topics World Trade
News headline image
QuidelOrtho (QDEL) Q3 2025 Earnings Transcript ↗
QuidelOrtho (QDEL) Q3 2025 Earnings Transcript 
Via The Motley Fool
Topics Supply Chain World Trade
News headline image
QuidelOrtho (NASDAQ:QDEL) Beats Q3 Sales Expectations
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell by 3.7% year on year to $699.9 million. The company expects the... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.